IL95588A0 - Pharmaceutical compositions containing paf-antagonists - Google Patents

Pharmaceutical compositions containing paf-antagonists

Info

Publication number
IL95588A0
IL95588A0 IL95588A IL9558890A IL95588A0 IL 95588 A0 IL95588 A0 IL 95588A0 IL 95588 A IL95588 A IL 95588A IL 9558890 A IL9558890 A IL 9558890A IL 95588 A0 IL95588 A0 IL 95588A0
Authority
IL
Israel
Prior art keywords
antagonists
pharmaceutical compositions
compositions containing
containing paf
paf
Prior art date
Application number
IL95588A
Other languages
English (en)
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of IL95588A0 publication Critical patent/IL95588A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
IL95588A 1989-09-07 1990-09-05 Pharmaceutical compositions containing paf-antagonists IL95588A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3929763A DE3929763A1 (de) 1989-09-07 1989-09-07 Paf-antagonisten zur herstellung eines arzneimittels, welches zur behandlung der durch verminderte ss-rezeptorstimulation verursachten herzkrankheiten geeignet ist

Publications (1)

Publication Number Publication Date
IL95588A0 true IL95588A0 (en) 1991-06-30

Family

ID=6388841

Family Applications (1)

Application Number Title Priority Date Filing Date
IL95588A IL95588A0 (en) 1989-09-07 1990-09-05 Pharmaceutical compositions containing paf-antagonists

Country Status (11)

Country Link
EP (1) EP0416604A3 (fr)
JP (1) JPH03106826A (fr)
KR (1) KR910005864A (fr)
AU (1) AU631921B2 (fr)
CA (1) CA2024630A1 (fr)
DD (1) DD299266A5 (fr)
DE (1) DE3929763A1 (fr)
HU (1) HU206830B (fr)
IE (1) IE903237A1 (fr)
IL (1) IL95588A0 (fr)
ZA (1) ZA907090B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3060287B2 (ja) * 1995-10-09 2000-07-10 参天製薬株式会社 アパファントを主薬とする水性点眼剤
KR100426429B1 (ko) * 2001-09-05 2004-04-08 김고명 난연성 저밀도 폴리에틸렌 발포수지의 제조방법
DE102005062417A1 (de) * 2005-12-27 2007-08-23 Korth, Ruth-Maria, Dr.med. Kompositionen mit spezifischen und unspezifischen Lipidantagonisten
US11039997B2 (en) 2005-12-27 2021-06-22 Ruth-Maria Korth Cosmetic, dermatic, protective compositions comprising phospholipids, lecithins with peptides and at least one acetylating compound
CN104758584A (zh) * 2015-03-16 2015-07-08 济南鸿飞生物技术有限公司 一种治疗急性心力衰竭的药剂及其制备方法
CN115286575A (zh) * 2022-06-24 2022-11-04 河南科技大学 一种喹啉酮并七八元环类衍生物及其合成方法和应用

Also Published As

Publication number Publication date
DD299266A5 (de) 1992-04-09
AU6226390A (en) 1991-03-14
KR910005864A (ko) 1991-04-27
ZA907090B (en) 1992-05-27
EP0416604A2 (fr) 1991-03-13
HU905810D0 (en) 1991-03-28
IE903237A1 (en) 1991-03-13
HUT59827A (en) 1992-07-28
JPH03106826A (ja) 1991-05-07
HU206830B (en) 1993-01-28
AU631921B2 (en) 1992-12-10
EP0416604A3 (en) 1992-02-05
DE3929763A1 (de) 1991-03-14
CA2024630A1 (fr) 1991-03-08

Similar Documents

Publication Publication Date Title
GB8926612D0 (en) Pharmaceutical compositions
ZW1790A1 (en) Pharmaceutical compositions
GB8909022D0 (en) Pharmaceutical compositions
GB9015437D0 (en) Pharmaceutical compositions
IL95588A0 (en) Pharmaceutical compositions containing paf-antagonists
GB2232891B (en) Pharmaceutical composition
HUT56269A (en) Pharmaceutical compositions
GB8909906D0 (en) Pharmaceutical compositions
GB8916071D0 (en) Pharmaceutical compositions
GB8902564D0 (en) Pharmaceutical compositions
GB8922149D0 (en) Pharmaceutical compositions
GB8914099D0 (en) Pharmaceutical compositions
IL89935A0 (en) Pharmaceutical compositions
GB8922130D0 (en) Pharmaceutical compositions
GB8909880D0 (en) Pharmaceutical compositions
GB8922129D0 (en) Pharmaceutical compositions
IE891521L (en) Pharmaceutical compositions
GB8919447D0 (en) Pharmaceutical compositions
GB8915044D0 (en) Pharmaceutical compositions
IE894216L (en) Pharmaceutical compositions
IE892803L (en) Pharmaceutical compositions
GB8919446D0 (en) Pharmaceutical compositions
GB8919130D0 (en) Pharmaceutical compositions
GB8917287D0 (en) Pharmaceutical compositions
GB8927109D0 (en) Pharmaceutical compositions